PHARMANET DEVELOPMENT GROUP IN PDGI (NASDAQ) $ 1.04 Change: -0.06 -5.77% | Volume: 427,065
Sponsored by Click here!

PHARMANET DEVLP - Fundamental Profile

Company Information

Ticker Symbol: PDGI
Exchange: NASD
Contact Info: 504 Carnegie Center Princeton NJ 08540-6242 609 951-6800
CEO/President: Jeffrey P. McMullen M.D.
Industry: Medical - Drugs / Standard Industry Code: 8731
Description: PharmaNet Development Group, Inc. is an international drug development services company offering a comprehensive range of clinical development, clinical and bioanalytical laboratory, and consulting services to the branded pharmaceutical, biotechnology, generic drug and medical device industries.

Share Information

Shares Outstanding: 19,470 (000) Market Value: 23,560 ($000)
Percentage of Inst.Shareholders: 93.96% Number of Inst.Shareholders: 2.10%
Last Quarter Sales: 109.39 ($Mil.) Last Quarter Net Income: -209.10 ($Mil.)
Last Quarter EPS: -10.73 P/E Ratio: 0
Most Recent Earnings: 0.08 on 10/29/08 Earnings Per Share: -10.94
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

PFIZER INC -34.60 15.28
JOHNSON AND JOH -20.70 55.33
BRISTOL MYERS S -27.60 19.36
SCHERING PLOUGH -42.70 15.55
MERCK CO INC -58.70 24.85